RHO federal: H7 RHA phase 2 study trial with adjuvants: terminate for the convenience of the government

Ended Awarded Last action

Contract number
HHSO10033001T
Awardee
Awarding agency
Obligated
$16,132,759

Award facts

Opportunity
  • 13100SOL00008 Solicitation number
Contract value 100% obligated
$16,132,759.35 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Chapel Hill, NC, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00015 -$24,152
Terminate for Convenience P00014 $0
Supplemental Agreement for work within scope P00013 · RHO federal: H7 RHA phase 2 study trial with adjuvants: appoint COR and extend POP $0
Supplemental Agreement for work within scope P00012 · The purpose of this modification is to effect key personnel changes as follows: blinded clinical team lead from: marina acosta-enslen to: babak fazeli… $0
Exercise an Option P00011 $9,442,561
Supplemental Agreement for work within scope P00010 $0
Supplemental Agreement for work within scope P00009 $0
Supplemental Agreement for work within scope P00008 · H7 RHA phase 2 study trial with adjuvants $0
Supplemental Agreement for work within scope 7 $0
Other Administrative Action 5 $0
Supplemental Agreement for work within scope 4 $0
Supplemental Agreement for work within scope 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $6,714,350
Show all 15

About this award

This is a $16,132,759.35 cost-plus-fixed-fee delivery order contract awarded to Rho Federal Systems Division Inc. by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract is part of the Medical Countermeasures Clinical Studies Network, an ASPR indefinite delivery/indefinite quantity (IDIQ) contract with a potential value of $250 million. Under this delivery order, Rho will provide a range of services including statistical analysis, data management, document sharing, and other clinical trial support for vaccine trials and research network coordination. Key subcontractors include Medpace, which will provide laboratory services, and Southern Research Institute, which will conduct preclinical safety, chemistry, pharmacokinetics, and toxicity testing. This contract is not set aside for any type of small business.

Quick answers

Who was awarded contract HHSO10033001T?

HHSO10033001T was awarded to Rho Federal Systems Division Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on May 2, 2017.

How much is contract HHSO10033001T worth?

The government has obligated $16,132,759 on HHSO10033001T.

Is contract HHSO10033001T an order under another contract?

Yes. HHSO10033001T is a delivery order under HHSO100201400004I, an indefinite delivery contract, on Medical Countermeasures Clinical Studies Network.

Was contract HHSO10033001T competed?

The extent of competition for HHSO10033001T was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award